Updated: FDA will reclassify at least a dozen peptides, teeing up potential telehealth win
更新：美国食品药品监督管理局将把至少十多种peptides重新分类，或为远程医疗带来潜在利好

The FDA threw its support behind a dozen peptides, announcing plans to reclassify them, likely presenting a huge money-making opportunity for what’s been a largely opaque market to date.
美国食品药品监督管理局支持了12种peptides，并宣布计划对其重新分类，这极有可能为迄今相对不透明的市场带来巨大的赚钱机遇。